Probiotics in the Management of Lung Diseases
Joint Authors
Paul Vos, Arjan
Adcock, Ian M.
Mortaz, Esmaeil
Barnes, Peter J.
Folkerts, Gert
Garssen, Johan
Source
Issue
Vol. 2013, Issue 2013 (31 Dec. 2013), pp.1-10, 10 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2013-05-08
Country of Publication
Egypt
No. of Pages
10
Main Subjects
Abstract EN
The physiology and pathology of the respiratory and gastrointestinal tracts are closely related.
This similarity between the two organs may underlie why dysfunction in one organ may induce illness in the other.
For example, smoking is a major risk factor for COPD and IBD and increases the risk of developing Crohn’s disease.
Probiotics have been defined as “live microorganisms which, when administered in adequate amounts, confer health benefits on the host.” In model systems probiotics regulate innate and inflammatory immune responses.
Commonly used probiotics include lactic acid bacteria, particularly Lactobacillus, Bifidobacterium, and Saccharomyces, and these are often used as dietary supplements to provide a health benefit in gastrointestinal diseases including infections, inflammatory bowel disease, and colon cancer.
In this respect, probiotics probably act as immunomodulatory agents and activators of host defence pathways which suggest that they could influence disease severity and incidence at sites distal to the gut.
There is increasing evidence that orally delivered probiotics are able to regulate immune responses in the respiratory system.
This review provides an overview of the possible role of probiotics and their mechanisms of action in the prevention and treatment of respiratory diseases.
American Psychological Association (APA)
Mortaz, Esmaeil& Adcock, Ian M.& Folkerts, Gert& Barnes, Peter J.& Paul Vos, Arjan& Garssen, Johan. 2013. Probiotics in the Management of Lung Diseases. Mediators of Inflammation،Vol. 2013, no. 2013, pp.1-10.
https://search.emarefa.net/detail/BIM-495838
Modern Language Association (MLA)
Mortaz, Esmaeil…[et al.]. Probiotics in the Management of Lung Diseases. Mediators of Inflammation No. 2013 (2013), pp.1-10.
https://search.emarefa.net/detail/BIM-495838
American Medical Association (AMA)
Mortaz, Esmaeil& Adcock, Ian M.& Folkerts, Gert& Barnes, Peter J.& Paul Vos, Arjan& Garssen, Johan. Probiotics in the Management of Lung Diseases. Mediators of Inflammation. 2013. Vol. 2013, no. 2013, pp.1-10.
https://search.emarefa.net/detail/BIM-495838
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-495838